IT & Data Management
Bruker Launches New timsTOF-based MALDI PharmaPulse Solution for Label-free HTS in Drug Discovery
Bruker Corporation announced the launch of its timsTOF MALDI PharmaPulse® (timsTOF MPP) system, a groundbreaking new high-end solution for unbiased, deep HTS and uHTS based on label-free mass spectrometry.
The new timsTOF® MPP is now the flagship of Bruker´s MALDI...
Press Releases
T2 Biosystems T2SARS-CoV-2 Panel Detects Omicron Subvariants
T2 Biosystems, Inc, a leader in the rapid detection of sepsis-causing pathogens, announced that its T2SARS-CoV-2™ Panel detects Omicron COVID-19 subvariants BA.1, BA.2, and BA.3.
According to the Centers for Disease Control and Prevention, the Omicron variant of the SARS-CoV-2...
Press Releases
Procaps Group Announces Capacity Expansion Plans in the United States with Construction of New Gummy Manufacturing Facility in Florida
Procaps Group, a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced a new capacity expansion plan in the United States and Colombia for its Funtrition business through a new gummy manufacturing facility and increased manufacturing capabilities to meet rising...
Press Releases
Castor Launches CRO Partnership Program to Increase Adoption of Decentralized Clinical Trials
Castor, a leading provider of decentralized and hybrid clinical trial solutions, announced the official launch of its CRO Partnership program. Designed to support clinical research organizations (CROs), the program provides the technical capabilities, operational training and commercial resources required...
Packaging & Labelling
The leading supplier of injection vials Gerresheimer expands production in Wertheim
Gerresheimer is expanding its capacities for glass vials at the Wertheim site and at two further sites in China and the USA. The company is investing in production in Wertheim to increase vials capacity by 150 million vials per...
Drug Research
Cytiva and NecstGen form strategic collaboration to accelerate development of cell and gene therapies
Cytiva, a global life sciences leader, and NecstGen, aim to accelerate the development of new cell and gene therapies globally via a strategic collaboration. Cytiva will provide its technologies, services, and solutions to NecstGen, and both organizations will share...
Clinical Trials
Valneva Announces Initiation of Adolescent Phase 3 Trial for its Single-Shot Chikungunya Vaccine Candidate
Valneva SE, a specialty vaccine company, announced the initiation of a Phase 3 trial in adolescents for its single-shot chikungunya vaccine candidate, VLA1553.
Funded by the Coalition for Epidemic Preparedness Innovations (CEPI), the trial is intended to support the label...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.